Cargando…
CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells
Medroxyprogesterone (MPA) is used for the conservative treatment of endometrial cancer. Unfortunately, progesterone resistance seriously affects its therapeutic effect. The purpose of the current study was to investigate the influence of deletion of AT-rich interactive domain 1A (ARID1A) in progeste...
Autores principales: | Wang, Haizhen, Tang, Zhenghua, Li, Ting, Liu, Menglu, Li, Yong, Xing, Baoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848330/ https://www.ncbi.nlm.nih.gov/pubmed/31072420 http://dx.doi.org/10.3727/096504019X15561873320465 |
Ejemplares similares
-
Endometrial progesterone resistance and PCOS
por: Li, Xin, et al.
Publicado: (2014) -
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
por: Yang, Shujie, et al.
Publicado: (2014) -
Progesterone Signaling in Endometrial Epithelial Organoids
por: Hewitt, Sylvia C., et al.
Publicado: (2022) -
Effects of dexamethasone on progesterone and estrogen profiles and uterine progesterone receptor localization during pregnancy in Sahel goat in Semi-Arid region
por: Yahi, Dauda, et al.
Publicado: (2017) -
The high concentration of progesterone is harmful for endometrial receptivity and decidualization
por: Liang, Yu-Xiang, et al.
Publicado: (2018)